Gene Electrotransfer of Plasmid Antiangiogenic Metargidin Peptide (AMEP) in Disseminated Melanoma: Safety and Efficacy Results of a Phase I First-in-Man Study-Reference-Cited by-同舟云学术

Gene Electrotransfer of Plasmid Antiangiogenic Metargidin Peptide (AMEP) in Disseminated Melanoma: Safety and Efficacy Results of a Phase I First-in-Man Study

Published:2013-09 Issue:3 Volume:24 Page:99-107
ISSN:2324-8637
Container-title:Human Gene Therapy Clinical Development
language:en
Short-container-title:Human Gene Therapy Clinical Development

Author:

Spanggaard Iben¹,Snoj Marko²,Cavalcanti Andrea³,Bouquet Céline⁴,Sersa Gregor²,Robert Caroline³,Cemazar Maja²,Dam Elisabeth⁴,Vasseur Bérangère⁴,Attali Pierre⁴,Mir Lluis M.³⁵⁶,Gehl Julie¹

Affiliation:

1. Department of Oncology, Center for Experimental Drug and Gene Electrotransfer, Copenhagen University Hospital Herlev, Herlev 2730, Denmark.

2. Institute of Oncology Ljubljana, 1000 Ljubljana, Slovenia.

3. Institut Gustave Roussy, 94805 Villejuif, France.

4. BioAlliance Pharma, 75015 Paris, France.

5. Unités Mixtes de Recherche 8203, Centre National de la Recherche Scientifique, 94800 Villejuif, France.

6. Unités Mixtes de Recherche 8203, Université Paris-Sud, 91405 Orsay, France.

Publisher

Mary Ann Liebert Inc

Subject

Genetics(clinical)

Link